INIBO 100U BOTULINUM TOXIN TYPE A
Purified neurotoxin complex (900 kDa) produced via Clostridium botulinum fermentation. Utilizes proprietary vacuum-drying technology ensuring >99.8% structural integrity and minimizing protein aggregation. Formulated with Human Serum Albumin (HSA) to prevent adherence to glass vials and maintain long-term stability. KFDA Certified (KLH No.2023-MD-0451). Strictly distributed for licensed clinical administration.
Composition per Vial
Active: Clostridium Botulinum Toxin Type A (100 Units)
Stabilizer: Human Serum Albumin (0.5 mg)
Tonicity Adjuster: Sodium Chloride (0.9 mg)
Appearance: White freeze-dried powder
Pharmacodynamics
Onset of Action: 48-72 hours post-injection
Peak Efficacy: 14 days post-administration
Clinical Duration: 3-6 months
Diffusion Radius: Controlled (< 3mm standard dilution)
Reconstitution Protocol & Standard Dosing
Reconstitute exclusively with sterile, preservative-free 0.9% Sodium Chloride. Gentle swirling is required; strictly prohibit aggressive agitation to prevent peptide bond denaturation. Administer via 30G-32G microneedle.
Dilution Ratio:
2.5ml Saline = 4.0U / 0.1ml
1.25ml Saline = 8.0U / 0.1ml
Target Topography:
Glabellar Complex: 20-30U
Lateral Canthal Lines: 12-24U
Frontalis: 10-20U
Storage & Contraindications
Unopened vials must be refrigerated at 2-8°C (35.6-46.4°F). Shelf life is 36 months from manufacturing date. Reconstituted solution must be utilized within 24 hours. Absolute contraindications include established hypersensitivity, active infection at injection site, and neuromuscular junction disorders (e.g., Myasthenia Gravis, Lambert-Eaton syndrome, ALS). Not evaluated for systemic administration.

Reviews
There are no reviews yet.